Northwestern Mutual Investment Management Company’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-4,445
| Closed | -$364K | – | 902 |
|
|
2021
Q2 | $364K | Buy |
4,445
+3
| +0.1% | +$246 | 0.01% | 866 |
|
|
2021
Q1 | $422K | Sell |
4,442
-4,423
| -50% | -$420K | 0.01% | 828 |
|
|
2020
Q4 | $550K | Sell |
8,865
-86
| -1% | -$5.34K | 0.01% | 825 |
|
|
2020
Q3 | $625K | Hold |
8,951
| – | – | 0.01% | 722 |
|
|
2020
Q2 | $625K | Sell |
8,951
-247
| -3% | -$17.2K | 0.01% | 724 |
|
|
2020
Q1 | $417K | Buy |
9,198
+1,156
| +14% | +$52.4K | 0.01% | 758 |
|
|
2019
Q4 | $523K | Sell |
8,042
-648
| -7% | -$42.1K | 0.01% | 754 |
|
|
2019
Q3 | $540K | Sell |
8,690
-271
| -3% | -$16.8K | 0.01% | 715 |
|
|
2019
Q2 | $638K | Buy |
8,961
+3,131
| +54% | +$223K | 0.02% | 650 |
|
|
2019
Q1 | $457K | Sell |
5,830
-611
| -9% | -$47.9K | 0.01% | 808 |
|
|
2018
Q4 | $545K | Buy |
+6,441
| New | +$545K | 0.01% | 758 |
|